Crinone 8% vaginal progesterone gel results in lower embryonic implantation efficiency after in vitro fertilization-embryo transfer

Fertility and Sterility

Volumn 72, Issue 5, 1999, Pages 830-836

  Damario, Mark A ^a,b   Goudas, Vasilios T ^a,b   Session, Donna R ^a,b   Hammitt, Diane G ^a,b   Dumesic, Daniel A ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Biochemical pregnancy; Implantation; In vitro fertilization; Luteal phase support; Progesterone

Indexed keywords

PROGESTERONE;

ADULT; ARTICLE; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; LUTEAL PHASE; NIDATION; PREGNANCY RATE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL;

ADMINISTRATION, INTRAVAGINAL; ADULT; EMBRYO IMPLANTATION; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; GELS; HUMANS; MULTIVARIATE ANALYSIS; PREGNANCY; PREGNANCY OUTCOME; PROGESTERONE; RETROSPECTIVE STUDIES;

EID: 0032745121     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(99)00364-7     Document Type: Article

References (22)

1. Soliman S., Daya S., Collins J., Hughes E.G. The role of luteal phase support in infertility treatment a meta-analysis of randomized trials . Fertil Steril. 61:1994;1068-1076.
2. McClure N., Leya J., Radwanska E., Rawlins R., RV Haning Jr. Luteal phase support and severe ovarian hyperstimulation syndrome. Hum Reprod. 7:1992;758-764.
3. Nahoul K., Dehennin L., Jondet M., Roger M. Profiles of plasma estrogens, progesterone, and their metabolites after oral or vaginal administration of estradiol or progesterone. Maturitas. 16:1993;185-202.
4. Smitz J., Devroey P., Faguer B., Bourgain C., Camus M., Van Steirteghem A.C. A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement. Hum Reprod. 7:1992;168-175.
5. Fanchin R., De Ziegler D., Bergeron C., Righini C., Torrisi C., Frydman R. Transvaginal administration of progesterone. Obstet Gynecol. 90:1997;396-401.
6. Anlar S., Capan U., Hincal A.A. Physico-chemical and bioadhesive properties of polyacrylic acid polymers. Pharmazie. 48:1993;285-287.
7. Casanas-Roux F., Nisolle M., Marbaix E., Smets M., Bassil S., Donnez J. Morphometric, immunohistological and three-dimensional evaluation of the endometrium of menopausal women treated by estrogen and Crinone, a new slow-release vaginal progesterone. Hum Reprod. 11:1996;357-363.
8. Fanchin R., De Ziegler D., Bergeron C., Rorrisi C., Frydman R. Transvaginal administration of progesterone. Obstet Gynecol. 90:1997;396-401.
9. De Ziegler D., Fanchin R., Massonneau M., Bergeron C., Frydman R., Bouchard P. Hormonal control of endometrial receptivity the egg donation model and controlled ovarian hyperstimulation . Ann N Y Acad Sci. 734:1994;209-220.
10. Damario M.A., Barmat L., Liu H.-C., Davis O.K., Rosenwaks Z. Dual suppression with oral contraceptives and gonadotropin-releasing hormone agonists improves in vitro fertilization outcome in high responder patients. Hum Reprod. 12:1997;2359-2365.
11. Palermo G.D., Cohen J., Alikani M., Adler A., Rosenwaks Z. Intracytoplasmic sperm injection a novel treatment for all forms of male factor infertility . Fertil Steril. 63:1995;1231-1240.
12. Fishel S., Jackson P., Webster J., Faratian B. Endotoxins in culture medium for human in vitro fertilization. Fertil Steril. 49:1988;108-111.
13. Cohen J., Alikani M., Trowbridge J., Rosenwaks Z. Implantation enhancement by selective assisted hatching using zona drilling of embryos with poor prognosis. Hum Reprod. 7:1992;685-691.
14. Zeger S.L., Liang K.-Y., Albert P.S. Models for longitudinal data a generalized estimating approach . Biometrics. 44:1988;1049-1060.
15. Pouly J.C., Bassil S., Frydman R., Hedon B., Nicollet B., Prada Y., et al. Luteal support after in-vitro fertilization Crinone 8%, a sustained release vaginal progesterone gel, versus Utrogestan, an oral micronized progesterone . Hum Reprod. 11:1996;2085-2089.
16. Gibbons W.E., Toner J.P., Hamacher P., Kolm P. Experience with a novel vaginal progesterone preparation in a donor oocyte program. Fertil Steril. 69:1998;96-101.
17. Zeyneloglu H.B., Arici A., Olive D.L. Adverse effects of hydrosalpinx on pregnancy rates after in vitro fertilization-embryo transfer. Fertil Steril. 70:1998;492-499.
18. Bergh C., Howles C.M., Borg K., Hamberger L., Josefsson B., Nilsson L., et al. Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP) results of a randomized comparative study in women undergoing assisted reproductive techniques . Hum Reprod. 12:1997;2133-2139.
19. Hedon D., Out H.J., Hugues J.N., Camier B., Cohen J., Lopes P., et al. Efficacy and safety of recombinant follicle-stimulating hormone (Puregon) in infertile women pituitary-suppressed with triptorelin undergoing in vitro fertilization a prospective, randomized, assessor-blind, multicentre trial . Hum Reprod. 10:1995;3102-3106.
20. Miles R.A., Paulson R.J., Lobo R.A., Press M.F., Dahmoush L., Sauer M.V. Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes a comparative study . Fertil Steril. 62:1994;485-490.
21. Kolb B.A., Paulson R.J. The luteal phase of cycles utilizing controlled ovarian hyperstimulation and the possible impact of this hyperstimulation on embryo implantation. Am J Obstet Gynecol. 176:1997;1262-1269.
22. Pellicer A., Valbuena D., Cano F., Remohi J., Simon C. Lower implantation rates in high responders evidence for an altered endocrine milieu during the preimplantation period . Fertil Steril. 65:1996;1190-1195.